HCW Biologics Inc. (HCWB) vs Onconetix, Inc. (ONCO)
- HCW Biologics Inc. HCWB 1.24 +0.81%
- Onconetix, Inc. ONCO 0.48 −12.73%
HCW Biologics Inc. and Onconetix, Inc. are both Biotechnology companies. HCW Biologics Inc. and Onconetix, Inc. are of similar size ($2.9M and $2.8M). HCW Biologics Inc. has negative trailing earnings, so its P/E is not meaningful; Onconetix, Inc. trades at 0.0×. HCW Biologics Inc. grew revenue faster over the last twelve months: 707.0% against −51.3%. HCW Biologics Inc. has the higher net margin (−329.4% vs −1,578.6%) and the higher return on invested capital (−36.2% vs −135.4%). Across the 17 metrics below, HCW Biologics Inc. leads on 9 and Onconetix, Inc. on 8.
Valuation
Profitability
| Metric | HCWB | ONCO | Biotechnology median |
|---|---|---|---|
| Gross margin | 95.91% | 80.38% | 65.16% |
| Operating margin | (114.02%) | (2,524.73%) | 0.00% |
| Net margin | (329.38%) | (1,578.60%) | 0.00% |
| Free cash flow margin | (180.57%) | (1,595.90%) | 0.00% |
| Return on equity | (600.32%) | (105.23%) | (56.36%) |
| Return on assets | (79.52%) | (57.37%) | (48.04%) |
| Return on invested capital | (36.15%) | (135.42%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack